University of Geneva
CH
Researchers
Public research profiles associated with University of Geneva.
Karl Blanchet
G. Alexandre
A. A. Abdelalim
J. F. Scott
Matthew Dawber
A. Dubreuil
Andréas Müller
Georg Ehret
Research from this institution
Publications linked through researcher authorship records.
Observation of a new particle in the search for the Standard Model Higgs boson with the ATLAS detector at the LHC
Genetic studies of body mass index yield new insights for obesity biology
Physics of thin-film ferroelectric oxides
This review covers important advances in recent years in the physics of thin-film ferroelectric oxides, the strongest emphasis being on those aspects particular to ferroelectrics in thin-film form. The authors introduce the current state of development in the application of ferroelectric thin films for electronic devices and discuss the physics relevant for the performance and failure of these devices. Following this the review covers the enormous progress that has been made in the first-principles computational approach to understanding ferroelectrics. The authors then discuss in detail the important role that strain plays in determining the properties of epitaxial thin ferroelectric films. Finally, this review ends with a look at the emerging possibilities for nanoscale ferroelectrics, with particular emphasis on ferroelectrics in nonconventional nanoscale geometries.
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
The Lancet Global Health Commission on Global Eye Health: vision beyond 2020
There is extensive evidence showing that improving eye health contributes directly and indirectly to achieving many Sustainable Development Goals, including reducing poverty and improving work productivity, general and mental health, and education and equity. Improving eye health is a practical and cost-effective way of unlocking human potential. Eye health needs to be reframed as an enabling, cross-cutting issue within the sustainable development framework.
Pharmaceutical pollution of the world’s rivers
Environmental exposure to active pharmaceutical ingredients (APIs) can have negative effects on the health of ecosystems and humans. While numerous studies have monitored APIs in rivers, these employ different analytical methods, measure different APIs, and have ignored many of the countries of the world. This makes it difficult to quantify the scale of the problem from a global perspective. Furthermore, comparison of the existing data, generated for different studies/regions/continents, is challenging due to the vast differences between the analytical methodologies employed. Here, we present a global-scale study of API pollution in 258 of the world's rivers, representing the environmental influence of 471.4 million people across 137 geographic regions. Samples were obtained from 1,052 locations in 104 countries (representing all continents and 36 countries not previously studied for API contamination) and analyzed for 61 APIs. Highest cumulative API concentrations were observed in sub-Saharan Africa, south Asia, and South America. The most contaminated sites were in low- to middle-income countries and were associated with areas with poor wastewater and waste management infrastructure and pharmaceutical manufacturing. The most frequently detected APIs were carbamazepine, metformin, and caffeine (a compound also arising from lifestyle use), which were detected at over half of the sites monitored. Concentrations of at least one API at 25.7% of the sampling sites were greater than concentrations considered safe for aquatic organisms, or which are of concern in terms of selection for antimicrobial resistance. Therefore, pharmaceutical pollution poses a global threat to environmental and human health, as well as to delivery of the United Nations Sustainable Development Goals.
Modelling and Assessing Experimental Competencies in Physics
The Data Ocean Project
Transparent use of commercial cloud resources for scientific experiments is a hard problem. In this article, we describe the first steps of the Data Ocean R&D collaboration between the high-energy physics experiment ATLAS together with Google Cloud Platform, to allow seamless use of Google Compute Engine and Google Cloud Storage for physics analysis. We start by describing the three preliminary use cases that were identified at the beginning of the project. The following sections then detail the work done in the data management system Rucio and the workflow management systems PanDA and Harvester to interface Google Cloud Platform with the ATLAS distributed computing environment, and show the results of the integration tests. Afterwards, we describe the setup and results from a full ATLAS user analysis that was executed natively on Google Cloud Platform, and give estimates on projected costs. We close with a summary and and outlook on future work.